GIP/GLP-1
Sort by:
ADA 2023 Insights
ADA 2023 Insights: Role for Amylin in Monotherapy and Combination Therapy for Obesity
FEATURING
David Lau
- 1,374 views
- July 14, 2023
- 11
Jefferson Health
Diabesity: New Trends in Management
FEATURING
Kevin Furlong
- 829 views
- November 23, 2023
- 11
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3
FEATURING
James Gavin Iii
- 647 views
- November 30, 2023
- 10
Primary Care Education Consortium
Cardiovascular and Kidney Outcomes With Glucose-Lowering Agents
FEATURING
James Gavin Iii
- 979 views
- November 21, 2023
- 8
Houston Methodist DeBakey Heart and Vascular Center
Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?
FEATURING
Kershaw Patel
- 1,913 views
- November 15, 2022
- 8
Icahn School of Medicine at Mount Sinai
Hot Topics in Chronic Kidney Disease Management
FEATURING
Samira Farouk
- 1,300 views
- July 10, 2023
- 8
Primary Care Education Consortium
Treatment Approaches for Obesity: Pharmacologic
FEATURING
Robert Kushner
- 1,535 views
- February 27, 2024
- 8
Canadian Collaborative Research Network
Can Patients Living With Obesity Really Lose Weight and How Will They Benefit?
FEATURING
Sean Wharton
- 552 views
- July 26, 2023
- 7
Houston Methodist Hospital
Obesity: Epidemiology and Medical Management in 2023
FEATURING
Archana Sadhu
- 1,369 views
- August 22, 2023
- 6
MUSC Cardiology
Where Lie the Keys to Treatment of Type 2 Diabetes Mellitus? Finding the Perfect Fit in Comprehensive Diabetes Treatment
FEATURING
Kathie Hermayer
- 705 views
- March 28, 2024
- 6
Jefferson Health
Beyond Glycemic Control: A New Paradigm in T2D Management
FEATURING
Intekhab Ahmed
- 1,064 views
- December 8, 2023
- 6
UCLA Health
The Past, Present and Future of Anti-Obesity Medications
FEATURING
James Hill
- 520 views
- May 10, 2024
- 5
Icahn School of Medicine at Mount Sinai
Chronic Kidney Disease and Hypertension: Panel Discussion
FEATURING
Samira Farouk,
Karim El Hachem
- 573 views
- July 10, 2023
- 5
Susan Brian
SURMOUNT 2: Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes
- 537 views
- April 26, 2024
- 4
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who
FEATURING
Qin Yang
- 948 views
- November 24, 2023
- 5
Keck School of Medicine of USC
Should Obesity Be the Treatment Target in Type 2 Diabetes?
FEATURING
Jaime Almandoz
- 501 views
- November 30, 2023
- 4
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4